Fundraising Fox
/People
Sign in

Houman Hemmati

Board director at Noveome Biotherapeutics

Beverly Hills, California, United States

Find your path to Houman

4 people in our graph share verified history with Houman — schools, employers, funds. One of them is your warm intro.

William GoldenunlockedHouman: together at Noveome Biotherapeutics
×3Houman: together at Noveome Biotherapeutics

About

Houman David Hemmati, M.D., Ph.D., is a board-certified ophthalmologist and Co-Founder and Chief Medical Officer of Optigo Biotherapeutics, a retina therapeutics company developing long-acting intravitreal drugs for wet macular degeneration and diabetic eye disease. He is also Co-Founder and Chief Scientific Officer of Levation Pharma, serves on the boards of Noveome Biotherapeutics, Trailhead Biosystems, and MediPrint Ophthalmics, and previously held roles at Vyluma, Capricor Therapeutics, and Allergan. Hemmati holds a B.S. from Stanford, an M.D. from UCLA, and a Ph.D. in Biology from Caltech, and is an Adjunct Assistant Clinical Professor of Ophthalmology at USC Keck School of Medicine.

Board director at Noveome Biotherapeutics

Intro paths

→

In turn, Houman can intro founders to Noveome Biotherapeutics's investors below.

Noveome Biotherapeutics's investors · 3

Carnegie Mellon Universitysince 2019Department of Defensesince 2011National Institutes of Health (NIH)since 2020

Experience

  1. Optigo BiotherapeuticsCo-Founder, Chief Medical Officercurrent2018 — presentVancouver, British Columbia, Canada
  2. Levation Pharma, Ltd.Co-Founder, Chief Scientific Officercurrent2017 — presentBeverly Hills, CA
  3. VylumaChief Medical Affairs Officercurrent2021 — presentBridgewater, New Jersey, United States
  4. Noveome Biotherapeutics, Inc.Member Board of Directorscurrent2022 — presentPittsburgh, Pennsylvania, United States
  5. Trailhead Biosystems Inc.Member Board Of Directorscurrent2020 — presentCleveland, Ohio, United States
  6. Lento BioMember Board of Directorscurrent2024 — presentNew York, United States
  7. Novateur Ventures Inc.Senior Ophthalmology Investment & Development Advisorcurrent2017 — presentVancouver, Canada Area
  8. Keck Medicine of USCAdjunct Clinical Assistant Professor, Ophthalmologycurrent2014 — presentGreater Los Angeles Area
  9. MediPrint OphthalmicsMember Board Of Directors2020 — 2025San Diego, California, United States
  10. Capricor Therapeutics, Inc.Vice President of Medical and Clinical Development for New Therapies2015 — 2017Beverly Hills, CA
  11. AllerganDirector, Clinical Development2013 — 2015Irvine, CA
  12. The Robert Larner, M.D. College of Medicine at The University of VermontAssistant Professor, Ophthalmology2012 — 2013Berlin, VT & Burlington, VT
  13. Harvard Medical SchoolCornea & Refractive Surgery Fellow - Massachusetts Eye & Ear - HMS Department of Ophthalmology2010 — 2012Greater Boston Area
  14. Massachusetts Institute of Technology (MIT)Postdoctoral Scholar2010 — 2012Cambridge, MA
  15. Johns Hopkins HospitalOphthalmology Resident - Wilmer Eye Institute2007 — 2010Baltimore, Maryland Area
  16. Stanford University Medical CenterInternal Medicine Intern2006 — 2007Palo Alto, CA
  17. GriffenRose, LLCMedical Expert2005 — 2007Greater New York City Area

Skills & more

OphthalmologyClinical ResearchMedical EducationMolecular BiologyMedicineSurgeryClinical TrialsLifesciencesHealthcareBiomedical EngineeringNeuroscienceBiotechnology
+12 moreCataractLASIKRefractive SurgeryCorneaCataract SurgeryOptometryDry EyeCancerStem CellsDrug DeliveryMedical DevicesHospitals

Languages Hebrew · Persian · Spanish

  • Controlled Substance Registration Certificate — United States Drug Enforcement Administration (DEA)
  • California Medical License — Medical Board of California
  • Board Certified, American Board of Ophthalmology

From Houman's professional profile.

Frequently asked questions

Who is Houman Hemmati?
Houman David Hemmati, M.D., Ph.D., is a board-certified ophthalmologist and Co-Founder and Chief Medical Officer of Optigo Biotherapeutics, a retina therapeutics company developing long-acting intravitreal drugs for wet macular degeneration and diabetic eye disease. He is also Co-Founder and Chief Scientific Officer of Levation Pharma, serves on the boards of Noveome Biotherapeutics, Trailhead Biosystems, and MediPrint Ophthalmics, and previously held roles at Vyluma, Capricor Therapeutics, and Allergan. Hemmati holds a B.S. from Stanford, an M.D. from UCLA, and a Ph.D. in Biology from Caltech, and is an Adjunct Assistant Clinical Professor of Ophthalmology at USC Keck School of Medicine.
Where does Houman Hemmati work?
Houman Hemmati is Board director at Noveome Biotherapeutics.
Where did Houman Hemmati go to school?
Houman Hemmati studied at David Geffen School of Medicine at UCLA (Doctor of Medicine (M.D.), 2006); Caltech (PhD, 2004); Stanford University (BS, Biological Sciences).

Same school

Shared employers

Also worked at The Robert Larner, M.D. College of Medicine at The University of Vermont1

Edward WeinsteinExecutive Officer, Director at Panome Bio